How to meet FDA requirements for demonstration of interchangeability?
There is a great interest from global companies who are developing biosimilars
Articles, journals and conferences in one search. An exact title, DOI or ISSN is listed first.
In the search box: "exact phrase" · -leave out · OR · prefix* · title: author: journal:
There is a great interest from global companies who are developing biosimilars
The microRNAs(miRNAs) are a type of non-coding RNAs molecules that
The success of biosimilar development involves demonstrating biosimilarity in terms of quality
Since originator recombinant proteins are getting off patent, biosimilar molecules are entering
A typical ice block is composed of numerous single ice crystals that
NBCD products are synthetic innovator-driven drug products and their copy versions
The development pathway of a biosimilar is unlike that of a novel
Recent expiration of a number of protein therapeutics opened up the door
Baoyuan Ma, Zhengfang Tian and Yufang Zhu PDF Share this article
Tasissa Ayela Wokuma and Mohammed Gebre Dedefo PDF Share this article
Anjing Zhu, Limin Chen and Yujia Li PDF Share this article
Shengyang Fu and Yufang Zhu PDF Share this article
Robert Bases and Rukmani Lekhraj PDF Share this article
Hunduma Dinsa Ayeno and Tesfaye Negesa Liche PDF Share this article
Gustavo H. Marin, Lupe Marin, Griselda Haag, Paula Risso and Jorge Errecalde
Ewa M. Guzik-Makaruk and Magda Olesiuk-Okomska PDF Share this article
Yancui Wang, Limin Chen and Yujia Li PDF Share this article
Ryan W.R. Guilbault, Morgan C. Smith, Priya J. Desai and Jaehwa Choi
Degarege Yazie, Workineh Shibeshi, Minyahil Alebachew and Alemseged Beyene Berha* PDF Share
Alexey Goltsov*, Zuzanna Kowalczyk and Rao VL Papineni* PDF Share this article
Campylobacter species is responsible for 400-500 million diarrhea cases worldwide every
Antibiotic resistance is an emerging problem in both developed and developing countries
For authors and organisers
Find the right journal for your paper and submit your manuscript.